TEYSUNO
As listed in the register: TEYSUNO 20 mg/5,8 mg/15,8 mg CAPSULAS DURAS
20 mg/5,8 mg/15,8 mg · cápsula dura
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Tegafur + gimeracilo + oteracilo
- Made by
- Nordic Group B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Nordic Group B.V. |
|---|---|
| Active substance | Tegafur + gimeracilo + oteracilo |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg/5,8 mg/15,8 mg |
| Form | cápsula dura |
| Classification | L01BC53 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | No — authorised but not currently marketed, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | TEYSUNO 20 mg/5,8 mg/15,8 mg CAPSULAS DURAS |
| Nº Registro | 111669004 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- cápsula dura4 products
15 mg/4,35 mg/11,8 mg2
15 mg/4,35 mg/11,8 mg · 2 companies
20 mg/5,8 mg/15,8 mg2
20 mg/5,8 mg/15,8 mg · 2 companies
- Nordic Group B.V. · this page
- Nordic Group B.V.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.